| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |